The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

10.1161/01.CIR.63.3.645

10.1161/01.CIR.82.5.1730

10.1016/0002-9149(93)90238-8

10.1016/S0002-9149(99)80353-1

10.1016/S0008-6363(97)00091-6

Wang W, 1994, Hypertension, 24, 571, 10.1161/01.HYP.24.5.571

10.1053/euhj.1998.1099

Rocha R, 1998, Hypertension, 31, 451, 10.1161/01.HYP.31.1.451

Capoten tablets: captopril tablets. In: Physicians' desk reference. 52nd ed. Montvale, N.J.: Medical Economics, 1998:784-7.

Vasotec tablets: enalapril maleate. In: Physicians' desk reference. 52nd ed. Montvale, N.J.: Medical Economics, 1998:1771-4.

10.1016/S0140-6736(98)90015-0

10.1056/NEJM199608153350707

Borghi C, 1993, J Clin Pharmacol, 33, 40, 10.1002/j.1552-4604.1993.tb03901.x

10.1136/hrt.52.5.530

10.1097/00005344-198211000-00014

10.1677/joe.0.0910457

10.1016/S0002-9149(96)00465-1

10.2307/2281868

Mantel N, 1966, Cancer Chemother Rep, 50, 163

Cox DR, 1972, J R Stat Soc [B], 34, 187

10.2307/2336502

10.2307/2530245

10.2307/2531910

10.1056/NEJM199108013250501

10.1056/NEJM198706043162301

10.1016/S0140-6736(98)11181-9

10.1056/NEJM199702203360801

10.1056/NEJM199610103351504

10.1056/NEJM199605233342101

10.1016/0002-9149(93)90243-6

10.1007/BF00877755

10.1016/S1071-9164(96)80009-1

Weber KT, 1991, Circulation, 83, 1849, 10.1161/01.CIR.83.6.1849

Brilla CG, 1990, Circ Res, 67, 1355, 10.1161/01.RES.67.6.1355

10.1016/0002-9149(93)90245-8

10.1006/jmcc.1993.1066

10.1016/S0140-6736(94)91164-9

Hobbs RE, 1998, Cleve Clin J Med, 65, 539, 10.3949/ccjm.65.10.539

10.1210/endo-128-5-2639

10.1016/S0024-3205(98)00150-7

10.1172/JCI119249

Aldactone: spironolactone. In: Physicians' desk reference. 53rd ed. Montvale, N.J.: Medical Economics, 1999:2928-9.

10.1016/0002-9149(87)91030-7

de Gasparo M, 1987, J Pharmacol Exp Ther, 240, 650